BridgeBio Oncology Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number
BridgeBio Oncology Therapeutics, Inc. (BBOT) reported Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number of 1.73 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber · last filed 2026-08-11
- BridgeBio Oncology Therapeutics, Inc. share-based compensation arrangement by share-based payment award, accelerated vesting, number for the quarter ending 2026-06-30 was 0.00 shares.
- BridgeBio Oncology Therapeutics, Inc. share-based compensation arrangement by share-based payment award, accelerated vesting, number for the quarter ending 2026-03-31 was 1.73M shares.
- BridgeBio Oncology Therapeutics, Inc. share-based compensation arrangement by share-based payment award, accelerated vesting, number for the quarter ending 2025-12-31 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 1.73M shares 10-Q · filed 2026-08-11 | 1.73M shares derived: sum of 3 quarters · filed 2026-08-11 | |
| 2026-03-31 | 1.73M shares 10-Q · filed 2026-05-12 | 1.73M shares derived: sum of 2 quarters · filed 2026-05-12 | ||
| 2025-12-31 | 0.00 shares derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-30 | 1.73M shares POS AM · filed 2026-04-30 | ||
| 2025-09-30 | 1.73M shares 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |